Back to Screener

Healthcare

Esperion Therapeutics, Inc.(ESPR)

Live Price

Offline

$3.16

+0.16% today

1Y Change

+218.18%

Window

Jun 27, 2025 โ†’ Jun 25, 2026

Market Cap
$650.00M
Revenue Growth
+21.3%
EPS Growth
+60.7%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 27, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Esperion Therapeutics, Inc. (ESPR) is a Healthcare stock with a market cap of $650.00M and listed on NASDAQ. The stock last traded around $3.15 and up 218.2% across the available one-year price window (Jun 27, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of +21.3%, EPS growth of +60.7%, a dividend yield of 0.0%. What stands out right now is revenue +21.3%, EPS +60.7%, free cash flow +46.2% with operating margin 15.0% and ROIC 23.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ESPR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ESPR vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

ESPR

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

ESPR Max Drawdown

-53.19%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ESPR and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est -0.04
โ€”
โ€”
Est 94874.7B
โ€”
May 5
โ€”
Mar 10, 26
โœ—
0.22
Est 0.23
-4.3%
168446.0B
Est 166446.1B
+1.2%
Mar 10
โ€”
Nov 6, 25
โœ—
-0.16
Est -0.09
-77.8%
87309.0B
Est 165122.1B
-47.1%
Nov 6
โ€”
Aug 5, 25
โœ“
-0.02
Est -0.17
+88.2%
82385.0B
Est 82471.4B
-0.1%
Aug 5
โ€”
May 6, 25
โœ—
-0.21
Est -0.18
-16.7%
64995.0B
Est 61227.2B
+6.2%
May 6
โ€”
Mar 4, 25
โœ“
-0.10
Est -0.14
+28.6%
69113.0B
Est 51700.7B
+33.7%
Mar 4
โ€”
Nov 7, 24
โœ—
-0.15
Est -0.14
-7.1%
51632.0B
Est 61555.2B
-16.1%
Nov 7
โ€”
Aug 12, 24
โœ“
-0.05
Est -0.15
+66.7%
73834.0B
Est 49060.0B
+50.5%
Aug 12
โ€”
May 7, 24
โœ“
0.34
Est 0.05
+580.0%
137735.0B
Est 84510.0B
+63.0%
May 7
โ€”
Feb 27, 24
โœ“
-0.50
Est -0.53
+5.7%
32250.0B
Est 28700.0B
+12.4%
Feb 27
โ€”
Nov 7, 23
โœ“
-0.37
Est -0.42
+11.9%
33969.0B
Est 29580.0B
+14.8%
Nov 7
โ€”
Aug 1, 23
โœ“
-0.46
Est -0.63
+27.0%
25786.0B
Est 24640.0B
+4.7%
Aug 1
โ€”
May 9, 23
โœ—
-0.79
Est -0.65
-21.5%
24329.0B
Est 22010.0B
+10.5%
May 9
โ€”
Feb 21, 23
โœ“
-0.76
Est -0.87
+12.6%
18818.0B
Est 20608.1B
-8.7%
Feb 21
โ€”
Nov 1, 22
โœ“
-0.81
Est -0.93
+12.9%
18980.0B
Est 19682.7B
-3.6%
Nov 1
โ€”
Aug 2, 22
โœ—
-1.05
Est -0.95
-10.5%
18841.0B
Est 18616.0B
+1.2%
Aug 2
โ€”
May 3, 22
โœ“
-0.93
Est -0.96
+3.1%
18836.0B
Est 15406.8B
+22.3%
May 3
โ€”
Feb 22, 22
โœ“
-1.77
Est -2.32
+23.7%
15401.0B
Est 14480.4B
+6.4%
Feb 22
โ€”
Nov 2, 21
โœ“
-2.62
Est -2.86
+8.4%
14409.0B
Est 16530.0B
-12.8%
Nov 2
โ€”
Aug 3, 21
โœ“
-1.67
Est -1.82
+8.2%
40659.0B
Est 40659.0B
0.0%
Aug 3
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.